**Background**: Nephron‐sparing surgery is currently an accepted treatment for renal cell carcinomas in patients with bilateral tumours, solitary kidneys and when overall renal function is impaired or at risk from medical disease. Its role in patients with a normal contralateral kidney remains contr
Current controversies in nephron-sparing surgery for renal-cell carcinoma
✍ Scribed by F. Steinbach; M. Stöckle; R. Hohenfellner
- Publisher
- Springer-Verlag
- Year
- 1995
- Tongue
- English
- Weight
- 301 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The role of nephron‐sparing surgery (NSS) showed promise in patients with metastatic renal cell carcinoma (MRCC). The disease‐specific survival of patients with MRCC was compared according to the type of surgery, NSS (N = 45) versus radical nephrectomy (RN) (N = 732), in
## Abstract ## BACKGROUND. The 2002 American Joint Committee on Cancer (AJCC) tumor classification for renal cell carcinoma (RCC) does not take into account concomitant venous invasion and extrarenal tumor extension (ERE). In the current study, the authors evaluated the prognostic significance of